Skip to main content

Philip Morris considers selling stake in pharmaceuticals unit to boost healthcare division

The company's wellness division has struggled, and Philip Morris has had talks with Deutsche Bank on a range of options.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.